Neuroprotective activity and acetylcholinesterase inhibition of five Amaryllidaceae species: a comparative study

Acetylcholinesterase inhibitors
Alzheimer’s disease
Amaryllidaceae alkaloids
Neuroprotective activity
Autores/as

Natalie Charlotte Cortés-Rendón

Rafael Andrés Posada-Duque

Rafael Mariano Álvarez-Quintero

Fernando Alveiro Alzate-Guarin

Strahil Berkov

Gloria Patricia Cardona-Gómez

Edison Javier Osorio-Durango

Fecha de publicación

2015-02-01

Doi

Abstract

Aims

Amaryllidaceae alkaloids exhibit a wide range of physiological effects, of which the acetylcholinesterase (AChE) inhibitory activity is the most relevant. However, scientific evidence related to their neuroprotective effectiveness against glutamate-induced toxicity has been lacking. Thus, the purpose of this study was to conduct a comparative study of the neuroprotective activity and the AChE inhibitory activity of species of Amaryllidaceae.

Main methods

The neuroprotective activity against glutamate-induced toxicity was measured in rat cortical neurons and the Ellman method was employed for the quantification of acetylcholinesterase inhibitory activity of alkaloidal extracts of five species of Amaryllidaceae (Crinum jagus, Crinum bulbispermum, Hippeastrum barbatum, Hippeastrum puniceum and Zephyranthes carinata). The alkaloid Amaryllidaceae patterns based on GC/MS analyses were also investigated.

Key findings

The results showed that the alkaloidal extract from C. jagus presented a high neuroprotective activity in both pre- and post-treatments against a glutamate excitotoxic stimulus. Furthermore, the alkaloid extracts from C. jagus and Z. carinata revealed an inhibitory activity of AChE from the electric eel with IC50 values of 18.28 ± 0.29 and 17.96 ± 1.22 μg/mL, respectively. In addition, 46 alkaloids were detected by GC/MS, and 20 of them were identified based on their mass spectra and retention index. The results suggest that the neuroprotective effects might be associated with lycorine and crinine-type alkaloids, whereas the acetylcholinesterase enzyme inhibitory activity could be related to galanthamine and lycorine-type alkaloids, although not based on synergistic processes.

Significance

In summary, Amaryllidaceae species are sources of alkaloids with potential use for Alzheimer’s disease.

Citation

Cortés-Rendón, N. C., Posada-Duque, R. A., Álvarez-Quintero, R. M., Alzate-Guarin, F. A., Berkov, S., Cardona-Gómez, G. P., & Osorio-Durango, E. J. (2015). Neuroprotective activity and acetylcholinesterase inhibition of five Amaryllidaceae species: A comparative study. Life Sciences, 122, 42–50. https://doi.org/10.1016/j.lfs.2014.12.011

Volver arriba